Spire Wealth Management bought a new stake in Haleon plc (NYSE:HLN – Free Report) during the 4th quarter, according to the ...
Haleon PLC closed 3.36% below its 52-week high of £4.01, which the company reached on September 18th.
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...
1d
HotCopper.com on MSNCutting deals for wellness – and Wellnex!Wellnex Life Ltd (ASX:WNX) is supplying the liquid softgel painkillers being sold by $60 billion UK giant Haleon under its ...
Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ...
Haleon-owned over-the-counter pain medication Panadol is making an effort to be more inclusive in its messaging.
The feature-length film from Sensodyne profiled several subjects in the neurodivergent and sensory sensitivity space, ...
The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless ...
5d
Stockhead on MSNBiocurious: Consumer health minnow Wellnex Life gears up for company-making EurotripWellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for ...
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...
(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results